Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Anti-Inflammatory and Cytokine Regulation BPC-157 downregulates pro-inflammatory mediators including: Tumor Necrosis Factor-Alpha (TNF-) Interleukin-1 Beta (IL-1) Interleukin-6 (IL-6) Leukotrienes key drivers of pain and inflammation in arthritis and tendinopathy Growth Hormone Receptor Upregulation Emerging research suggests BPC-157 increases growth hormone receptor density in injured tissues, amplifying the natural repair signals that decline with age or chronic inflammation
Serious reactions are rare, but they happen when safety protocols slip
Serum potassium should be closely observed the first 48 hours and potassium should be administered if necessary
Misconception 2: A mechanism reported in animals will translate to humans
The information below reflects USP standards, manufacturer prescribing information, published trial protocols, and self-reported community sources
